Semaglutide and lifestyle support for heart health in breast cancer survivors
Treatments studied
Part of Cancer, Heart & circulation, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a weekly injection called semaglutide (a weight-loss medication) combined with lifestyle support can improve heart and blood vessel health in postmenopausal women who have had breast cancer and are currently taking an aromatase inhibitor. It may help reduce weight and lower the risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 46 and 55 years old
- You have been through menopause (no periods for at least 12 months)
- You were diagnosed with early-stage breast cancer (stage 1, 2, or 3) within the last 5 years
- You are currently taking an aromatase inhibitor
- Your body mass index (BMI) is 30 or higher
- You have not had chemotherapy, radiation, or immunotherapy for your breast cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This trial is testing whether a weight-loss medication called semaglutide combined with a hormonal intrauterine device (IUD) can help treat early-stage endometrial cancer or precancerous changes, allowing patients who want to preserve fertility or avoid surgery to do so. The study also includes a structured weight loss program.
This trial studies whether semaglutide can improve heart and blood-vessel outcomes in people with type 1 diabetes who use an insulin pump or automated insulin delivery. It may help reduce cardiovascular risks, but you must meet several health and medication-safety requirements.
This trial tests a weekly injection (semaglutide) to see if it can help lower the risk of heart disease and type 2 diabetes in women who recently had gestational diabetes. The goal is to improve long-term health after pregnancy.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
Hear when a new Anatomic Stage I Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.